Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

248.22
BATS BZX Real-Time Price
As of 12:53pm ET
 +1.06 / +0.43%
Today’s Change
184.50
Today|||52-Week Range
301.32
+18.19%
Year-to-Date
AGN Regular Dividend: AGN will begin trading ex-dividend on 02/24/17 with a $0.70 dividend payable to shareholders of record as of 02/28/17.
Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
11:26am / Zacks.com - Paid Partner Content
Big pharma bets billions on 'silent' liver disease
Feb 21 / FT.com - Paid Partner Content
Go With Allergan, Celgene and 'Big Mo'
10:04am / TheStreet.com - Paid Partner Content
Riddle Me This; Bendable Market: Best of Kass
Feb 17 / TheStreet.com - Paid Partner Content
Where Are the Best Buying Opportunities in Stocks Right Now?
Feb 21 / Zacks.com - Paid Partner Content
Deals of the Week: Valentine Couplings and Breakups
Feb 17 / TheStreet.com - Paid Partner Content
Medtronic Earnings Rebound in Third Quarter, Shares Climb
Feb 21 / TheStreet.com - Paid Partner Content
Wills Financial Group, Inc. Buys The Travelers, Allergan PLC, Danaher, Sells Eaton Va...
Feb 17 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Alle...
Feb 21 / Zacks.com - Paid Partner Content
Financial Partners Capital Management Llc Buys Realogy Holdings, Allergan PLC, BP PLC...
Feb 17 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close247.16
Today’s open247.26
Day’s range246.74 - 249.00
Volume84,076
Average volume (3 months)4,784,227
Market cap$92.7B
Dividend yield1.13%
Data as of 12:53pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+18.68%
Earnings growth (next 5 years)+11.50%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene+0.01+0.01%
BMYBristol-Myers Squibb+1.40+2.56%
LLYEli Lilly and Co+0.52+0.65%
ABBVAbbVie+0.02+0.03%
Data as of 12:53pm ET, 02/22/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$3.40
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs